Pages
All Departments
Let's get Social
Copyright Here. All rights reserved.
BYWWW.NEJM.ORGJuly 15, 2017
Methods. We conducted an open-label, phase 3 trial comparing crizotinib with chemotherapy in 343 patients with advanced ALK-positive nonsquamous NSCLC who had ...